These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34866084)

  • 21. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3R
    Parducci NS; Garnique ADMB; Lima K; Carlos JAEG; Fonseca NP; de Miranda LBL; de Almeida BO; Rego EM; Traina F; Machado-Neto JA
    Blood Cells Mol Dis; 2024 Jan; 104():102799. PubMed ID: 37839173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Allogeneic Stem Cell Transplantation with Ruxolitinib Maintenance Therapy for
    Ye P; Lin Q; Jin M; Gu X; Lu Y
    Turk J Haematol; 2023 Feb; 40(1):73-74. PubMed ID: 36510384
    [No Abstract]   [Full Text] [Related]  

  • 24. CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis.
    Zhang X; Ghiuzeli C; Jou E; Hsu P; Kolitz J; Brody JP
    Leuk Res Rep; 2022; 17():100334. PubMed ID: 35795468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.
    Maxson JE; Luty SB; MacManiman JD; Abel ML; Druker BJ; Tyner JW
    J Biol Chem; 2014 Feb; 289(9):5820-7. PubMed ID: 24403076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
    Dao KT; Gotlib J; Deininger MMN; Oh ST; Cortes JE; Collins RH; Winton EF; Parker DR; Lee H; Reister A; Schultz ; Savage S; Stevens ; Brockett C; Subbiah N; Press RD; Raess PW; Cascio M; Dunlap J; Chen Y; Degnin C; Maxson JE; Tognon CE; Macey T; Druker BJ; Tyner JW
    J Clin Oncol; 2020 Apr; 38(10):1006-1018. PubMed ID: 31880950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid Disease with the CSF3R T618I Mutation after CLL.
    Couto ME; Bizarro S; Sousa D; Domingues N; Oliveira I; Martins G; Teixeira MR; Mariz M
    Case Rep Hematol; 2020; 2020():6670965. PubMed ID: 33414971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.
    Pardanani A; Lasho TL; Laborde RR; Elliott M; Hanson CA; Knudson RA; Ketterling RP; Maxson JE; Tyner JW; Tefferi A
    Leukemia; 2013 Sep; 27(9):1870-3. PubMed ID: 23604229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A CSF3R T618I Mutation in a Patient with Chronic Neutrophilic Leukemia and Severe Bleeding Complications.
    Mitsumori T; Komatsu N; Kirito K
    Intern Med; 2016; 55(4):405-7. PubMed ID: 26875968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.
    Ouyang Y; Qiao C; Chen Y; Zhang SJ
    Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eighty-year-old man with rare chronic neutrophilic leukemia caused by
    Li YP; Chen N; Ye XM; Xia YS
    World J Clin Cases; 2020 Dec; 8(24):6337-6345. PubMed ID: 33392315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients.
    Aref S; El-Ghonemy M; Abouzeid T; El-Sabbagh A; El-Baiomy M
    Leuk Res; 2014 Jun; 38(6):722-5. PubMed ID: 24746896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring
    Sahara N; Yokoyama K; Matsunaga T; Kitahara S; Fujii T; Kobayashi S; Yusa N; Shimizu E; Imoto S; Tojo A; Ohno N
    Leuk Res Rep; 2022; 18():100348. PubMed ID: 36119729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal evolution in a chronic neutrophilic leukemia patient.
    Zhang QG; Wang J; Gong WY; Jing QC
    Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management.
    Elliott MA; Tefferi A
    Am J Hematol; 2014 Jun; 89(6):651-8. PubMed ID: 24845374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
    Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A
    Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's different about atypical CML and chronic neutrophilic leukemia?
    Dao KH; Tyner JW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():264-71. PubMed ID: 26637732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.
    Tefferi A; Thiele J; Vannucchi AM; Barbui T
    Leukemia; 2014 Jul; 28(7):1407-13. PubMed ID: 24441292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.